» Articles » PMID: 32710351

Factors Associated with Thyroid Disorders and Iodine Adequacy in Pregnant Saudi Women

Overview
Date 2020 Jul 26
PMID 32710351
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Little is known about iodine adequacy and gestational thyroid disorders (GTDs) in Saudi Arabia. This study measured the rates of GTDs and iodine adequacy in 810 healthy Saudi women. Concentrations of serum thyroid hormones and 24-h urine iodine (24-h UIC), and GTDs were diagnosed according to the American Thyroid Association guidelines. Dietary and socioeconomic data to determine factors associated with GTDs and iodine insufficiency were collected. GTDs were detected in 265 women (32.7%) as follows: subclinical (SCH; 20.2%) and overt (OH; 5.8%) hypothyroidism, isolated hypothyroxinemia (ISH; 4.7%) and hyperthyroidism (2%). The SCH (109.2 μg/L; IQR: 77.2-149.7), OH (95.3 μg/L; IQR: 74.3-130.5) and ISH (107.3 μg/L; IQR: 65.5-133.1) groups had median 24-h UIC below the WHO recommended limit, whereas the euthyroid (191.4 μg/L; IQR: 170.03-219.8) and hyperthyroid (159.5 μg/L; IQR: 152.9-238.3) groups were iodine sufficient. Numbers of pregnancies, less education, not consuming iodized salt and not using iodine supplements increased risk of hypothyroidism and ISH. Contrariwise, interval ≥ 3 years from last pregnancy and higher 24-h UIC decreased odds of hypothyroidism and ISH. Moreover, dairy products and egg consumption were markedly lower in all GTD groups. Dairy products and seafood consumption correlated independently with 24-h UIC of the study participants, whereas consuming yogurt, eggs, redfish and shellfish protected against GTDs. In conclusion, GTDs appear to be prevalent in pregnant Saudi women and the hypothyroid and hypothyroxinemia groups had iodine insufficiency. However, consuming iodized salt, iodine supplements, dairy products, seafoods and eggs may protect against GTDs.

Citing Articles

Iodine nutritional status and its associations with thyroid function of pregnant women and neonatal TSH.

Fan L, Bu Y, Chen S, Wang S, Zhang W, He Y Front Endocrinol (Lausanne). 2024; 15:1394306.

PMID: 38883600 PMC: 11176414. DOI: 10.3389/fendo.2024.1394306.

References
1.
Alexander E, Pearce E, Brent G, Brown R, Chen H, Dosiou C . 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017; 27(3):315-389. DOI: 10.1089/thy.2016.0457. View

2.
Rotondi M, Capelli V, Chiovato L, Nappi R . 2017 ATA guidelines on the management of thyroid dysfunctions in pregnancy: what do OB/GYNs need to know?. Gynecol Endocrinol. 2019; 35(4):276-279. DOI: 10.1080/09513590.2018.1532496. View

3.
Dong A, Stagnaro-Green A . Differences in Diagnostic Criteria Mask the True Prevalence of Thyroid Disease in Pregnancy: A Systematic Review and Meta-Analysis. Thyroid. 2018; 29(2):278-289. DOI: 10.1089/thy.2018.0475. View

4.
Pearce E, Lazarus J, Moreno-Reyes R, Zimmermann M . Consequences of iodine deficiency and excess in pregnant women: an overview of current knowns and unknowns. Am J Clin Nutr. 2016; 104 Suppl 3:918S-23S. PMC: 5004501. DOI: 10.3945/ajcn.115.110429. View

5.
Lopez-Munoz E, Mateos-Sanchez L, Mejia-Terrazas G, Bedwell-Cordero S . Hypothyroidism and isolated hypothyroxinemia in pregnancy, from physiology to the clinic. Taiwan J Obstet Gynecol. 2019; 58(6):757-763. DOI: 10.1016/j.tjog.2019.09.005. View